We now show that ZC3H18 is a key cellular target of EBV that is upregulated in lymphoma lines that exhibit latency I, EBV-transformed cell lines in latency III, and EBV+ DLBCL in latency II/III. This evidence concerns the gene ZC3H18 and lymphoma.